CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 303 filers reported holding CONCENTRIX CORP in Q2 2024. The put-call ratio across all filers is 1.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,284 | -4.5% | 51,913 | 0.0% | 0.04% | -5.1% |
| Q1 2024 | $3,437 | -32.6% | 51,913 | 0.0% | 0.04% | -36.1% |
| Q4 2023 | $5,097 | +22.6% | 51,913 | -0.0% | 0.06% | +15.1% |
| Q3 2023 | $4,159 | -1.1% | 51,933 | -0.3% | 0.05% | +6.0% |
| Q2 2023 | $4,205 | -34.3% | 52,093 | -1.1% | 0.05% | -34.2% |
| Q1 2023 | $6,404 | -8.8% | 52,691 | -0.1% | 0.08% | -12.6% |
| Q4 2022 | $7,020 | -99.9% | 52,731 | -6.2% | 0.09% | +3.6% |
| Q3 2022 | $6,275,000 | +25.7% | 56,220 | +52.7% | 0.08% | +37.7% |
| Q2 2022 | $4,992,000 | -49.8% | 36,808 | -38.3% | 0.06% | -41.9% |
| Q1 2022 | $9,935,000 | -6.7% | 59,653 | +0.0% | 0.10% | +1.9% |
| Q4 2021 | $10,654,000 | +1.4% | 59,651 | +0.4% | 0.10% | -2.8% |
| Q3 2021 | $10,510,000 | +22.6% | 59,387 | +11.3% | 0.11% | +21.8% |
| Q2 2021 | $8,576,000 | +624.3% | 53,339 | +574.2% | 0.09% | +569.2% |
| Q1 2021 | $1,184,000 | +79.4% | 7,911 | +18.2% | 0.01% | +85.7% |
| Q4 2020 | $660,000 | – | 6,694 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |